TPS03--Imaging: The Final Frontier

Chair(s)

• 

  Rachel Eddy, PhD

  University of British Columbia
• 

  Stacey Martiniano, MD

  Childrens Hospital Colorado and University of Colorado

Presentations:

• 2:30 PM - 4:00 PM PDT

  Changes in lung function and lung ventilation following commencement of Elexacaftor - Tezacaftor - Ivacaftor in a ≤6 year old cohort
  

  Speaker: Martin Donnelley – University of Adelaide / Women's and Children's Hospital
• 2:30 PM - 4:00 PM PDT

  Quantitative CT scoring of mucus plugs in people with Cystic Fibrosis
  

  Speaker: Margherita S. Silani, n/a
• 2:30 PM - 4:00 PM PDT

  Structural lung abnormalities in children and adults with cystic fibrosis after ETI using AI automated algorithms
  

  Speaker: Daan Caudri, MD, PhD – Erasmus MC - Sophia Children's Hospital
• 2:30 PM - 4:00 PM PDT

  Elexacaftor/Tezacaftor/Ivacaftor is associated with improvements in mucus plugging, air trapping and bronchial thickening but not bronchial widening in people with CF aged 12 years and older
  

  Speaker: Paul McNally – RCSI University of Medicine and Health Sciences
• 2:30 PM - 4:00 PM PDT

  Olfactory function and sinonasal opacification improve in young children with cystic fibrosis treated with elexacaftor/tezacaftor/ivacator (ETI)
  

  Speaker: Eugene Oh, MSE – David Geffen School of Medicine at UCLA
• 2:30 PM - 4:00 PM PDT

  Assessment of lung disease in people with cystic fibrosis using electrical impedance tomography
  

  Speaker: Heather Boas, M.D. – Children's Hospital of Philadelphia
• 2:30 PM - 4:00 PM PDT

  Effect of inhaled dry-powder mannitol on mucociliary clearance in moderate to severe CF lung disease while using elexacaftor/tezacaftor/ivacaftor
  

  Speaker: Subhashini A. Sellers, MD, MSCR – University of North Carolina at Chapel Hill
• 2:30 PM - 4:00 PM PDT

   Elexacaftor-Tezacaftor-Ivacaftor reduces bronchial dilatations in adolescents with Cystic Fibrosis
  

  Speaker: Isabelle Sermet-Gaudelus – INSERM
• 2:30 PM - 4:00 PM PDT

  Do CT images accurately identify inflammatory ‘hotspots’ in the CF lung
  

  Speaker: Georgia Ann Bateman, n/a
• 2:30 PM - 4:00 PM PDT

  Body fat distribution impacts glucose and insulin secretory indices in people with cystic fibrosis
  

  Speaker: Lucia Gonzalez Ramirez – Emory University